Literature DB >> 8828487

Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors.

L M Bilezikjian1, A Z Corrigan, A L Blount, W W Vale.   

Abstract

Follistatins, activins, and inhibins are expressed in a wide range of tissues where they function as autocrine and/or paracrine factors. Activin B (beta B beta B) and inhibin B (alpha beta B) are the predominant forms expressed in the rat anterior pituitary. This study was designed to evaluate the regulation of the messenger RNAs (mRNAs) for inhibin alpha and beta B, and follistatin, relative to each other, using cultured rat anterior pituitary cells. Activin A stimulated follistatin (a maximal 4-fold stimulation by 6 h) and beta B (a maximal 1.7-fold stimulation after 2 h) mRNA levels. Although inhibin A dramatically decreased follistatin mRNA levels (34% of the control value after 24 h), it only marginally affected those of beta B (86% of the control value after 2 h). Follistatin inhibited the accumulation of its own mRNA (46% of the control value after 6 h), but had no statistically significant effect on beta B or alpha mRNA levels. Inhibin A was the only treatment that had an effect on alpha mRNA levels, causing a slight decrease (82% of the control value by 24 h). The effects of activin A and inhibin A on follistatin and beta B mRNA levels were dose dependent. Moreover, follistatin and inhibin A blocked the effects of activin A. Immunoneutralization experiments were performed to determine whether locally secreted activin B regulates the expression of these three mRNAs. A monoclonal antibody to activin B reduced follistatin and beta B mRNA levels (37% and 73% of the control value, respectively) and enhanced the stimulatory effect of exogenous activin A on these mRNAs (840% vs. 300% and 170% vs. 145% of the control value, respectively); there was no change in alpha mRNA accumulation. GnRH and activators of the protein kinase A (forskolin) and protein kinase C (12-O-tetradecanoylphorbol acetate) pathways also had differential effects on follistatin, beta B, and alpha mRNA levels. GnRH stimulated follistatin mRNA levels, but suppressed those of beta B. 12-O-Tetraphorbol acetate had no effect on beta B, but stimulated follistatin mRNA levels to the same extent as forskolin. Of these agents, only forskolin produced a marginal inhibitory effect on alpha mRNA accumulation. Testosterone decreased both follistatin and beta B mRNA levels without affecting those of alpha. The results of this study demonstrate that the local production of rat anterior pituitary follistatin, activin B, and inhibin B is regulated by hypothalamic, peripheral, and local factors in such a way that the ratios between activin B and its two inactivators, follistatin and inhibin B, are very tightly maintained.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828487     DOI: 10.1210/endo.137.10.8828487

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.

Authors:  K Lewis; C Li; M H Perrin; A Blount; K Kunitake; C Donaldson; J Vaughan; T M Reyes; J Gulyas; W Fischer; L Bilezikjian; J Rivier; P E Sawchenko; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

2.  The Local Control of the Pituitary by Activin Signaling and Modulation.

Authors:  Louise M Bilezikjian; Wylie W Vale
Journal:  Open Neuroendocrinol J       Date:  2011-01-01

Review 3.  Neuroendocrine, autocrine, and paracrine control of follicle-stimulating hormone secretion.

Authors:  Vasantha Padmanabhan; Rodolfo C Cardoso
Journal:  Mol Cell Endocrinol       Date:  2019-11-02       Impact factor: 4.102

Review 4.  Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.

Authors:  Louise M Bilezikjian; Nicholas J Justice; Alissa N Blackler; Ezra Wiater; Wylie W Vale
Journal:  Mol Cell Endocrinol       Date:  2012-02-04       Impact factor: 4.102

5.  Transcriptional activation of the ovine follicle-stimulating hormone-beta gene by gonadotropin-releasing hormone involves multiple signal transduction pathways.

Authors:  Vyacheslav V Vasilyev; Flavia Pernasetti; Suzanne B Rosenberg; Mark J Barsoum; Darrell A Austin; Nicholas J G Webster; Pamela L Mellon
Journal:  Endocrinology       Date:  2002-05       Impact factor: 4.736

6.  Weaning and the developmental changes in follicle-stimulating hormone, pituitary adenylate cyclase-activating polypeptide, and inhibin B in the male rat.

Authors:  Joseph P Moore; Stephen J Winters
Journal:  Biol Reprod       Date:  2007-12-26       Impact factor: 4.285

7.  Synergistic induction of follicle-stimulating hormone beta-subunit gene expression by gonadal steroid hormone receptors and Smad proteins.

Authors:  Varykina G Thackray; Pamela L Mellon
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

8.  Upregulation of activin signaling in experimental colitis.

Authors:  You-Qing Zhang; Silvia Resta; Barbara Jung; Kim E Barrett; Nora Sarvetnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-30       Impact factor: 4.052

9.  Androgen regulates follicle-stimulating hormone beta gene expression in an activin-dependent manner in immortalized gonadotropes.

Authors:  Thomas J Spady; Rana Shayya; Varykina G Thackray; Lisa Ehrensberger; Janice S Bailey; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2003-12-30

Review 10.  Hormones in synergy: regulation of the pituitary gonadotropin genes.

Authors:  Varykina G Thackray; Pamela L Mellon; Djurdjica Coss
Journal:  Mol Cell Endocrinol       Date:  2009-09-10       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.